Tokai Pharmaceuticals
hormone-dependent growth disorders
Tokai was founded by Apple Tree Partners to in-license and develop endocrine-based therapies for major diseases. The company’s primary focus is on its proprietary Specific Androgen Receptor Modulator/Lyase Inhibitor (TOK-001) for Castration...Homepage: http://www.tokaipharma.com/
Total money raised: $45M
Tokai Pharmaceuticals
02142 One Broadway11th floor
Cambridge
USA MA
Phone: 6172254305
Updated on Mar 31, 2013
Tokai Pharmaceuticals at CrunchBase
Jodie Morrison CEOTokai Pharmaceuticals at CrunchBase
Seth Harrison Board of Directors
Past
Martin D. Williams President and CEO
September, 2011
Tokai Pharmaceuticals raised $23M in a Series D round from Novartis Venture Fund and Apple Tree Partners
Tokai Pharmaceuticals Raises $23 Million in Funding 
eon.businesswire.com
June, 2009
Tokai Pharmaceuticals raised $22M in a Series D round from Apple Tree Partners and Novartis Venture Fund
Tokai Pharmaceuticals, Inc.: Series D $22M 
onbiovc.com